Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene variations may increase the risk of alopecia, and platelet-rich plasma treatment can improve hair density in those with hair loss; a rare case of facial Becker's nevus was linked to uneven beard growth.

A 17-year-old girl and her brothers have a rare hair condition with long eyelashes, thick eyebrows, and easily pluckable hair.

A new classification and scoring system is needed for alopecia areata to better assess severity.

A family got a fungal infection from a boy who had contact with rabbits, but they all recovered with treatment.

The conclusion is that fat tissue in the skin is a new finding in Frontal fibrosing alopecia and may contribute to hair follicle and muscle degeneration.

The woman has a rare skin condition called follicular Dowling-Degos disease, which has limited treatment options.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

Early biopsy and targeting inflammation can improve treatment for hair loss in androgenetic alopecia.

Various potential triggers may be causing the rise in frontal fibrosing alopecia, and avoiding these could help stop the disease's increase.

A new surgical method using special sutures significantly reduced wound size and prevented disease return in patients with a scarring scalp condition.

A fungal infection developed on a herpes scar and was successfully treated with antifungal medication.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

The woman's scalp condition caused hair loss and scarring, but the exact cause is unknown.

The study found clear differences in lesion distribution and microscopic features among trichostasis spinulosa, keratosis pilaris, and eruptive vellus hair cysts.

No effective treatment exists to stimulate hair growth in atrichia with papular lesions.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Fibrosing alopecia in a pattern distribution is a type of hair loss that may often be overlooked, especially in men.

Mutations in Far2 mice cause hair loss due to sebaceous gland issues.

The condition is likely inherited in an autosomal-dominant pattern.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Two patients with a rare scalp fungus in Poland were successfully treated with griseofulvin and ciclopirox.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Autoimmune and inflammatory processes are involved in both scarring and non-scarring types of hair loss.

Excessive sun protection might contribute to frontal fibrosing alopecia.

The link between pemphigus and the patient's scarring hair loss is still unclear.